Literature DB >> 30951378

Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis.

Chongxiang Xiong1,2, Yingjie Guan1, Xiaoxu Zhou1, Lirong Liu1, Michelle A Zhuang1, Wei Zhang1, Yunhe Zhang1, Monica V Masucci1, George Bayliss1, Ting C Zhao3, Shougang Zhuang1,4.   

Abstract

In this study, we examined the effect of MC1568, a selective class IIa histone deacetylase (HDAC) inhibitor, on the development and progression of renal fibrosis in a murine model of renal fibrosis induced by unilateral ureteral obstruction (UUO). All 4 class IIa HDAC isoforms, in particular HDAC4, were up-regulated in renal epithelial cells of the injured kidney. Administration of MC1568 immediately after UUO injury reduced expression of α-smooth muscle actin (α-SMA), fibronectin, and collagen 1. MC1568 treatment or small interfering RNA-mediated silencing of HDAC4 also suppressed expression of those proteins in cultured renal epithelial cells. Mechanistically, MC1568 abrogated UUO-induced phosphorylation of Smad3, NF-κB, and up-regulation of integrin ɑVβ6 in the kidney and inhibited TGF-β1-induced responses in cultured renal epithelial cells. MC1568 also increased renal expression of klotho, bone morphogenetic protein 7, and Smad7. Moreover, delayed administration of MC1568 at 3 d after ureteral obstruction reversed the expression of α-SMA, fibronectin, and collagen 1 and increased expression of matrix metalloproteinase (MMP)-2 and -9. Collectively, these results suggest that selectively targeting class IIa HDAC isoforms (in particular HDAC4) may inhibit development and progression of renal fibrosis by suppressing activation and expression of multiple profibrotic molecules and increasing expression of antifibrotic proteins and MMPs.-Xiong, C., Guan, Y., Zhou, X., Liu, L., Zhuang, M. A., Zhang, W., Zhang, Y., Masucci, M. V., Bayliss, G., Zhao, T. C., Zhuang, S. Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis.

Entities:  

Keywords:  HDAC4; MC1568; inflammation; renal epithelial cells; unilateral ureteral obstruction

Year:  2019        PMID: 30951378      PMCID: PMC6593874          DOI: 10.1096/fj.201801067RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  59 in total

1.  The integrin alphaVbeta6 binds and activates latent TGFbeta3.

Authors:  Justin P Annes; Daniel B Rifkin; John S Munger
Journal:  FEBS Lett       Date:  2002-01-30       Impact factor: 4.124

2.  Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.

Authors:  Junwei Yang; Ryan W Shultz; Wendy M Mars; Rodney E Wegner; Yingjian Li; Chunsun Dai; Kari Nejak; Youhua Liu
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

3.  Decreased matrix metalloproteinase activity in the kidneys of hereditary nephrotic mice (ICGN strain).

Authors:  K Uchio; N Manabe; K Tamura; M Miyamoto; M Yamaguchi; A Ogura; Y Yamamoto; H Miyamoto
Journal:  Nephron       Date:  2000-10       Impact factor: 2.847

4.  Decreased expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in the kidneys of hereditary nephrotic (ICGN) mice.

Authors:  Kozue Uchio-Yamada; Noboru Manabe; Yasufumi Goto; Sayuri Anann; Yoshie Yamamoto; Kaoru Takano; Atsuo Ogura; Junichiro Matsuda
Journal:  J Vet Med Sci       Date:  2005-01       Impact factor: 1.267

5.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.

Authors:  J S Munger; X Huang; H Kawakatsu; M J Griffiths; S L Dalton; J Wu; J F Pittet; N Kaminski; C Garat; M A Matthay; D B Rifkin; D Sheppard
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

6.  Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models.

Authors:  Michael Zeisberg; Cindy Bottiglio; Navin Kumar; Yohei Maeshima; Frank Strutz; Gerhard A Müller; Raghu Kalluri
Journal:  Am J Physiol Renal Physiol       Date:  2003-08-12

7.  Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.

Authors:  Li-Jun Ma; Haichun Yang; Ariana Gaspert; Gianluca Carlesso; Melissa M Barty; Jeffrey M Davidson; Dean Sheppard; Agnes B Fogo
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

8.  Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis.

Authors:  Rujun Gong; Abdalla Rifai; Evelyn M Tolbert; Jason N Centracchio; Lance D Dworkin
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

9.  Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat.

Authors:  Christine Maric; Kathryn Sandberg; Carmen Hinojosa-Laborde
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121

10.  BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.

Authors:  Michael Zeisberg; Jun-ichi Hanai; Hikaru Sugimoto; Tadanori Mammoto; David Charytan; Frank Strutz; Raghu Kalluri
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

View more
  22 in total

1.  Exogenous pancreatic kininogenase protects against renal fibrosis in rat model of unilateral ureteral obstruction.

Authors:  Ji-Zhe Jin; Hui-Ying Li; Jian Jin; Shang-Guo Piao; Xiong-Hu Shen; Yan-Ling Wu; Jia-Chong Xu; Long-Ye Zhang; Yu-Ji Jiang; Hai-Lan Zheng; Ying-Shun Jin; Sheng Cui; Kang Luo; Yi Quan; Can Li
Journal:  Acta Pharmacol Sin       Date:  2020-04-16       Impact factor: 6.150

Review 2.  Epigenetics in kidney diseases.

Authors:  Hao Ding; Lu Zhang; Qian Yang; Xiaoqin Zhang; Xiaogang Li
Journal:  Adv Clin Chem       Date:  2020-10-21       Impact factor: 6.303

3.  Identification of molecular mechanism and key biomarkers in membranous nephropathy by bioinformatics analysis.

Authors:  Zhaocheng Dong; Yunling Geng; Pingna Zhang; Jingyi Tang; Zijing Cao; Huijuan Zheng; Jing Guo; Chao Zhang; Baoli Liu; Wei Jing Liu
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

4.  Pharmacological and Genetic Inhibition of HDAC4 Alleviates Renal Injury and Fibrosis in Mice.

Authors:  Fengchen Shen; Xiying Hou; Tingting Li; Jianjun Yu; Huizhen Chen; Na Liu; Andong Qiu; Shougang Zhuang
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

5.  Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte Injury.

Authors:  Xu He; Tao Sun; Pei Zhang; Zhengkun Xia; Chunlin Gao; Hongqi Ren; Daxi Ji
Journal:  Front Med (Lausanne)       Date:  2022-04-14

6.  Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.

Authors:  Yunhe Zhang; Jianan Zou; Evelyn Tolbert; Ting C Zhao; George Bayliss; Shougang Zhuang
Journal:  FASEB J       Date:  2020-04-12       Impact factor: 5.191

7.  Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury.

Authors:  Wei Zhang; Yinjie Guan; George Bayliss; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2020-10-05

Review 8.  Epigenetic modifications of Klotho expression in kidney diseases.

Authors:  Jinkun Xia; Wangsen Cao
Journal:  J Mol Med (Berl)       Date:  2021-02-06       Impact factor: 4.599

9.  Histone Deacetylase 11 Contributes to Renal Fibrosis by Repressing KLF15 Transcription.

Authors:  Lei Mao; Li Liu; Tao Zhang; Hao Qin; Xiaoyan Wu; Yong Xu
Journal:  Front Cell Dev Biol       Date:  2020-04-17

10.  Histone deacetylase 3 aberration inhibits Klotho transcription and promotes renal fibrosis.

Authors:  Fang Chen; Qi Gao; Ai Wei; Xingren Chen; Yujun Shi; Hongwei Wang; Wangsen Cao
Journal:  Cell Death Differ       Date:  2020-10-06       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.